influenza
common
reason
primari
care
consult
constitut
lead
caus
hospitalis
morbid
mortal
worldwid
noninfluenza
virus
common
caus
ill
clinic
resembl
influenza
particularli
children
data
epidemiolog
diseas
burden
influenzarel
diseas
southeast
asia
sea
emerg
turn
shed
light
epidemiolog
viral
bacteri
aetiolog
influenzalik
ill
ili
hospitalis
adult
children
region
insight
provid
inform
import
futur
prevent
strategi
treatment
clinic
manag
respiratori
infect
also
guid
futur
studi
region
recent
mani
diagnost
advanc
made
order
help
determin
aetiolog
acut
respiratori
infect
advanc
made
possibl
molecular
diagnost
techniqu
widespread
use
furthermor
research
field
gain
much
attent
fund
due
outbreak
sever
acut
respiratori
syndrom
coronaviru
sarscov
avian
influenza
virus
sea
middl
eastern
respiratori
syndrom
coronaviru
merscov
middl
east
gener
caus
agent
ili
remain
undiagnos
routin
clinic
practic
due
expens
test
slow
turnaround
time
diagnost
polymeras
chain
reaction
pcr
consid
long
impact
manag
usual
selflimit
respiratori
tract
infect
howev
increas
use
antivir
drug
neuraminidas
inhibitor
influenza
test
ili
pathogen
may
becom
import
ration
antivir
drug
treatment
prevent
overus
antibiot
therebi
help
control
cost
prevent
emerg
spread
antimicrobi
drug
resist
past
year
sever
novel
caus
agent
ili
identifi
respiratori
specimen
includ
human
metapneumoviru
new
human
coronavirus
sarscov
merscov
rhinoviru
c
continu
emerg
novel
lineag
subtyp
influenza
viru
capabl
infect
human
virus
diseas
causat
yet
establish
also
identifi
includ
human
bocaviru
respiratori
polyomavirus
like
mani
come
comprehens
data
caus
ili
origin
develop
countri
data
avail
sea
recent
studi
publish
asian
countri
provid
much
need
valuabl
inform
show
similar
spectrum
viral
pathogen
studi
design
determin
viral
atyp
bacteri
aetiolog
ili
patient
sea
use
molecular
techniqu
detect
influenza
virus
respiratori
pathogen
influenza
virus
specimen
sent
routin
influenza
test
provid
valuabl
insight
epidemiolog
ili
across
age
group
three
sea
countri
time
period
furthermor
studi
could
address
potenti
occurr
multipl
simultan
infect
patient
perform
laboratorybas
surveil
studi
test
archiv
respiratori
specimen
hospitalis
patient
year
juli
june
clinic
diagnos
ili
meet
follow
criteria
age
year
sign
ili
accord
treat
physician
durat
ili
symptom
day
respiratori
specimen
sent
influenza
test
clinician
particip
hospit
receiv
regular
train
protocol
manag
recognit
influenzaili
archiv
respiratori
specimen
nose
swab
throat
swab
nasopharyng
aspir
nasal
wash
tracheal
aspir
bronchoalveolar
lavag
obtain
site
three
countri
across
sea
three
site
indonesia
four
site
thailand
five
site
vietnam
influenza
test
capac
creat
randomis
clinic
studi
compar
two
dosag
oseltamivir
sever
influenza
site
south
east
asia
infecti
diseas
clinic
research
network
describ
elsewher
specimen
use
studi
store
test
one
specimen
type
avail
patient
prioritis
sequenc
endotrach
aspiratebronchoalveolar
lavag
nasopharyng
aspir
throat
swab
nasal
swab
wash
retrospect
studi
addit
test
archiv
specimen
full
anonymis
specimen
approv
institut
review
board
site
commerci
avail
multiplex
polymeras
chain
reaction
pcr
gel
electrophoresi
assay
seeplex
ace
detect
seeplex
pneumobact
ace
seegen
south
korea
use
detect
major
respiratori
virus
six
respiratori
bacteri
pathogen
influenza
virus
b
respiratori
syncyti
virus
rsv
b
rhinovirus
ab
coronavirus
adenoviru
parainfluenza
virus
human
metapneumoviru
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
serotyp
bordetella
pertussi
addit
inhous
realtim
reversetranscriptas
rt
pcr
use
detect
follow
virus
rhinovirus
b
c
enterovirus
parainfluenza
viru
bocaviru
parechovirus
chlamydophila
psittaci
describ
elsewher
basic
demograph
data
countri
sex
age
collect
well
date
diseas
onset
date
admiss
type
specimen
intens
care
unit
icu
admiss
analysi
result
streptococcu
pneumonia
haemophilu
influenza
pcr
taken
account
high
posit
rate
result
nasopharyng
carriag
respect
studi
data
shown
baselin
demograph
characterist
age
categori
sex
countri
admiss
proport
icu
admiss
summaris
frequenc
proport
frequenc
differ
pathogen
summaris
per
countri
sex
age
categori
determin
frequent
virus
bacteria
stratum
diseas
outcom
includ
sever
sever
defin
icu
admiss
death
durat
hospitalis
durat
ill
examin
regress
analysi
depend
binari
outcom
sever
diseas
death
presenc
pathogen
analys
logist
regress
adjust
age
sex
kaplanmei
surviv
analysi
use
visualis
number
hospitalis
day
age
categori
patient
death
censor
cox
regress
use
analys
whether
virus
found
often
durat
ill
present
hospit
shorter
regress
analysi
base
data
vietnam
thailand
relev
clinic
data
miss
indonesia
statist
softwar
sa
version
sa
institut
inc
cari
nc
usa
use
comput
twosid
p
valu
less
interpret
statist
signific
total
patient
sampl
collect
particip
site
tabl
summaris
demograph
data
median
number
day
ill
onset
specimen
collect
iqr
day
patient
exact
admiss
date
known
major
patient
studi
age
patient
enrol
vietnam
n
median
age
higher
indonesian
patient
compar
vietnam
thailand
year
versu
year
year
respect
one
hundr
patient
admit
intens
care
unit
icu
icu
admiss
data
patient
unknown
indonesia
thailand
vietnam
sixtyseven
patient
mechan
ventil
overal
report
inhospit
mortal
n
detect
bacteri
pathogen
pneumonia
n
c
psittaci
n
c
pneumonia
n
b
pertussi
n
l
pneumophila
n
fluctuat
frequenc
found
particular
month
sever
virus
rsv
occur
juli
novemb
rhinoviru
peak
march
figur
due
differ
age
group
represent
number
viral
agent
detect
per
patient
lower
indonesia
vietnam
thailand
likewis
proport
identifi
viral
agent
detect
rsv
higher
thailand
vietnam
indonesia
respect
compar
whilst
coronaviru
greater
proport
identifi
viral
agent
indonesia
thailand
vietnam
see
tabl
pathogen
detect
countri
patient
least
two
pathogen
detect
bacteri
andor
viral
patient
found
two
pathogen
patient
three
pathogen
nine
patient
four
pathogen
one
patient
five
pathogen
frequenc
pathogen
shown
tabl
pathogen
commonli
detect
patient
two
pathogen
bocaviru
n
rhinoviru
n
proport
patient
either
viru
bacterium
detect
appear
decreas
age
highest
proport
pathogen
detect
age
group
increas
older
viral
pathogen
common
children
parechoviru
parainfluenza
viru
found
children
tabl
pneumonia
found
patient
younger
year
whilst
case
c
psittacii
occur
patient
year
icu
admiss
countri
shown
tabl
number
patient
mechan
ventil
vietnam
thailand
data
avail
indonesia
vietnames
data
set
data
complet
icu
admiss
relat
age
children
age
year
three
age
year
age
year
age
year
age
year
admit
icu
v
trend
p
logist
regress
perform
data
set
includ
covari
pathogen
type
viru
bacteri
neither
age
sex
analysi
show
higher
age
associ
icu
admiss
adjust
icu
admiss
age
year
compar
age
year
p
tabl
specif
pathogen
associ
icu
admiss
suffici
data
avail
analys
durat
hospitalis
patient
vietnam
median
durat
hospitalis
day
iqr
day
multivari
cox
regress
analysi
hospitalis
day
pathogen
type
viru
bacteri
neither
sex
age
perform
pathogen
type
p
age
categori
p
signific
effect
found
patient
group
hospitalis
longer
differ
sex
influenza
virusposit
patient
admit
median
day
iqr
day
versu
day
iqr
day
patient
influenza
detect
similar
pattern
seen
coronaviru
median
day
iqr
day
posit
patient
versu
day
iqr
day
neg
group
patient
pneumoniaeposit
admit
longer
median
day
iqr
day
versu
median
day
iqr
day
death
viral
pathogen
detect
influenza
viru
n
rhinoviru
n
bocaviru
n
coronaviru
n
parainfluenza
viru
n
rsv
n
one
combin
influenza
adenoviru
rhinoviru
data
concern
caus
death
collect
studi
consequ
conclus
causat
drawn
influenzalik
ill
major
caus
mortal
morbid
worldwid
especi
younger
elderli
age
group
suggest
larg
proport
iliattribut
death
global
occur
africa
sea
data
regard
aetiolog
respiratori
infect
sea
limit
avail
data
suggest
virus
account
larg
proport
infect
studi
use
molecular
techniqu
detect
virus
atyp
bacteria
sampl
collect
patient
hospitalis
ili
major
patient
enrol
studi
enrol
vietnam
age
ili
diagnost
surveil
nose
throat
swab
consid
sampl
method
choic
wherea
diagnost
h
influenza
pneumonia
gramstain
bacteri
cultur
repres
purul
sputum
blood
cultur
urinari
antigen
test
pneumonia
would
test
method
choic
done
detect
rate
two
pathogen
therefor
includ
analysi
studi
potenti
pathogen
identifi
patient
rate
higher
previous
publish
rate
organ
identifi
studi
look
aetiolog
respiratori
tract
infect
differ
asian
countri
total
studi
cohort
found
posit
virus
compar
cohort
atyp
bacteri
pathogen
alon
detect
recent
studi
form
asian
countri
use
molecular
techniqu
shown
rate
viru
detect
reach
common
virus
detect
studi
rhinovirus
account
patient
viral
pathogen
detect
cohort
whole
similar
studi
variat
three
countri
proport
patient
viral
pathogen
detect
variat
rel
import
differ
virus
larg
repres
differ
age
group
sampl
younger
patient
vietnam
thailand
higher
proport
rsv
detect
bocavirus
first
describ
sinc
numer
studi
describ
detect
human
respiratori
tract
possibl
associ
diseas
causat
convincingli
proven
studi
viru
detect
patient
similar
studi
detect
rate
rang
previou
studi
well
studi
detect
bocaviru
predominantli
young
children
rather
adult
studi
studi
bocavirus
commonli
bocaviru
isol
studi
tabl
detect
combin
pathogen
commonli
rhinoviru
atyp
bacteria
rare
detect
rate
detect
lower
previous
publish
data
detect
vari
howev
includ
serolog
diagnost
method
atyp
bacteria
true
preval
patient
may
higher
commonli
detect
atyp
bacteria
studi
pneumonia
follow
c
psittaci
l
pneumophila
result
studi
similar
aetiolog
studi
communityacquir
pneumonia
singapor
malaysia
pneumonia
commonest
atyp
pathogen
detect
littl
known
epidemiolog
c
psittaci
sea
inde
pathogen
recent
describ
caus
human
diseas
vietnam
type
pathogen
detect
significantli
associ
durat
hospitalis
atyp
bacteria
particular
infect
pneumonia
associ
longer
durat
hospitalis
age
patient
also
significantli
associ
longer
durat
hospitalis
year
age
group
requir
longer
admiss
probabl
correspond
increas
comorbid
decreas
immun
age
similar
region
world
clear
season
seen
variou
pathogen
detect
rate
infect
appear
higher
winter
spring
month
studi
singl
year
may
miss
season
trend
rate
influenza
viru
increas
indonesia
vietnam
april
coincid
epidem
season
influenza
vietnam
prior
first
sporad
case
detect
end
may
strength
type
studi
includ
larg
number
patient
enrol
prospect
three
differ
countri
southeast
asia
allow
overview
viral
atyp
bacteri
caus
ili
region
studi
also
use
rtpcr
techniqu
howev
import
limit
lack
microscopi
sputum
cultur
common
bacteria
associ
ili
pneumonia
h
influenza
type
b
serolog
atyp
pathogen
also
limit
clinic
data
record
case
make
difficult
assess
clinic
signific
variou
pathogen
detect
virul
pathogen
although
swab
patient
meet
elig
criteria
analys
data
concern
number
patient
may
admit
ili
swab
lack
clinic
data
also
limit
comparison
site
differ
admiss
criteria
may
impact
distribut
pathogen
similarli
lack
clinic
data
absenc
data
concern
overal
admiss
limit
abil
interpret
find
relat
icu
admiss
find
adult
patient
overrepres
amongst
admit
icu
could
repres
differenti
routin
sampl
adult
children
unit
howev
feel
unlik
lack
data
relat
patient
comorbid
immunosuppress
copd
could
also
impact
sever
infect
seen
furthermor
lack
suitabl
control
patient
also
limit
abil
determin
attribut
fraction
ili
like
caus
viru
also
prevent
use
analysi
relev
high
rate
nasopharyng
carriag
pneumonia
h
influenza
type
b
establish
aetiolog
ili
becom
increasingli
import
establish
burden
variou
pathogen
order
improv
manag
prevent
also
guid
antivir
treatment
tri
limit
inappropri
use
antimicrobi
reduc
emerg
spread
antibiot
resist
studi
along
overwhelm
evid
mani
studi
countri
suggest
viral
caus
ili
much
common
bacteri
caus
viral
aetiolog
may
vari
space
time
recent
year
emerg
sarscov
merscov
avian
influenza
virus
highlight
risk
pose
respiratori
viral
infect
human
sea
becom
area
increas
interest
monitor
pathogen
littl
publish
region
regard
incid
preval
viral
atyp
organ
contribut
ili
make
studi
look
increasingli
import
addit
support
inform
may
found
onlin
version
articl
tabl
frequenc
detect
pathogen
countri
tabl
frequenc
pathogen
found
combin
anoth
pathogen
